Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with psychiatric disorders. It offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment for adult patients with major depressive disorder. The company's NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed MRI-strength magnetic field, which induces electrical currents designed to stimulate specific areas of the brain associated with mood. Neuronetics, Inc. was incorporated in 2003 and is headquartered in Malvern, Pennsylvania.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:STIM
CUSIPN/A
Phone610-640-4202
Debt
Debt-to-Equity Ratio-0.13
Current Ratio1.75
Quick Ratio1.59
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$40.43 million
Price / Sales10.81
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
Employees167
Outstanding Shares17,580,000
Market Cap$407.08 million
Neuronetics (NASDAQ:STIM) Frequently Asked Questions
What is Neuronetics' stock symbol?
Neuronetics trades on the NASDAQ under the ticker symbol "STIM."
How were Neuronetics' earnings last quarter?
Neuronetics Inc (NASDAQ:STIM) posted its quarterly earnings data on Tuesday, August, 14th. The company reported ($30.60) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.84) by $29.76. The business earned $13.25 million during the quarter, compared to analyst estimates of $12.20 million. View Neuronetics' Earnings History.
When is Neuronetics' next earnings date?
What price target have analysts set for STIM?
5 Wall Street analysts have issued 12-month target prices for Neuronetics' stock. Their forecasts range from $33.00 to $40.00. On average, they anticipate Neuronetics' share price to reach $36.3333 in the next twelve months. This suggests a possible upside of 46.2% from the stock's current price. View Analyst Price Targets for Neuronetics.
What is the consensus analysts' recommendation for Neuronetics?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Neuronetics in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Neuronetics.
Who are some of Neuronetics' key competitors?
Some companies that are related to Neuronetics include Nevro (NVRO), Mazor Robotics (MZOR), Cardiovascular Systems (CSII), Luminex (LMNX), Atrion (ATRI), Cryolife (CRY), Tactile Systems Technology (TCMD), K2M Group (KTWO), AtriCure (ATRC), Orthofix Medical (OFIX), OraSure Technologies (OSUR), Cerus (CERS), Intersect ENT (XENT), SurModics (SRDX) and AngioDynamics (ANGO).
Who are Neuronetics' key executives?
Neuronetics' management team includes the folowing people:
- Mr. Christopher A. Thatcher, CEO, Pres & Director (Age 53)
- Mr. Peter L. Donato, VP & CFO (Age 48)
- Mr. Gregory Harper, VP of R&D, Operations and Product Devel. (Age 57)
- Mr. Stephen MacKinnon, VP of Sales
- Ms. Cassie Hallberg, VP of Marketing
When did Neuronetics IPO?
(STIM) raised $75 million in an IPO on Thursday, June 28th 2018. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. Piper Jaffray and William Blair acted as the underwriters for the IPO and Canaccord Genuity, BTIG and JMP Securities were co-managers.
When does the company's lock-up period expire?
Neuronetics' lock-up period expires on Tuesday, December 25th. Neuronetics had issued 5,500,000 shares in its public offering on June 28th. The total size of the offering was $93,500,000 based on an initial share price of $17.00. After the expiration of the company's lock-up period, company insiders and major shareholders will be able to sell their shares of the company.
How do I buy shares of Neuronetics?
Shares of STIM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Neuronetics' stock price today?
One share of STIM stock can currently be purchased for approximately $24.86.
How big of a company is Neuronetics?
Neuronetics has a market capitalization of $407.08 million and generates $40.43 million in revenue each year. Neuronetics employs 167 workers across the globe.
What is Neuronetics' official website?
How can I contact Neuronetics?
Neuronetics' mailing address is 3222 PHOENIXVILLE PIKE, MALVERN PA, 19355. The company can be reached via phone at 610-640-4202 or via email at [email protected]
MarketBeat Community Rating for Neuronetics (NASDAQ STIM)
MarketBeat's community ratings are surveys of what our community members think about Neuronetics and other stocks. Vote "Outperform" if you believe STIM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe STIM will underperform the S&P 500 over the long term. You may vote once every thirty days.
